The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction

Cardiovascular Drugs and Therapy

Volumn 15, Issue 1, 2001, Pages 79-87

  Pitt, B ^a,b,c   Williams, G ^a,b,c   Remme, W ^a,b,c   Martinez, F ^a,b,c   Lopez Sendon, J ^a,b,c   Zannad, F ^a,b,c   Neaton, J ^a,b,c   Roniker, B ^a,b,c   Hurley, S ^a,b,c   Burns, D ^a,b,c   Bittman, R ^a,b,c   Kleiman, J ^a,b,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPLERENONE;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART FAILURE; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; SYSTOLE;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; DOUBLE-BLIND METHOD; HEART FAILURE, CONGESTIVE; HUMANS; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SAMPLE SIZE; SPIRONOLACTONE; SURVIVAL ANALYSIS; SYSTOLE;

EID: 0034916015     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011119003788     Document Type: Article

References (67)

1. Relation of the reninangiotensin-aldosterone system to clinical state in congestive heart failure
2. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
3. Aldosterone and antialdosterone therapy in congestive heart failure
4. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease
5. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
6. Three new epoxyspironolactone derivatives: Characterization in vivo and in vitro
7. Development and evaluation of the Kansas City cardiomyopathy questionnaire: A new health status measure for heart failure
8. Measuring health-related quality of life
9. Monitoring the quality of life in patients with coronary artery disease
10. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity
11. A shorter form health survey: Can the SF-12 replicate results from the SF-36 longitudinal studies?
12. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. International Quality of Life Assessment Project
13. The EuroQoL instrument: An index of health-related quality of life
14. Measurement of health state utilities for economic appraisal
15. Development of a brief screening instrument for detecting depressive disorders
16. The brief symptom inventory: An introductory report
17. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
18. Angiotensin-converting enzyme inhibition after myocardial infarction: The trandolapril cardiac evaluation study
19. The acute infarction ramipril efficacy (AIRE) study: Rationale, design, organization, and outcome definitions
20. Letters to the editor
21. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients
22. Sample size calculation for complex clinical trials with survival endpoints
23. Safety concerns about digoxin after acute myocardial infarction
24. Asymptotically efficient rank invariant procedures
25. Nonparametric estimation from incomplete observations
26. Regression models and life-tables
27. Discrete sequential boundaries for clinical trials
28. Spironolactone in the long-term management of patients with congestive heart failure
29. Spironolactone in the management of congestive heart failure: A review
30. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion
31. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat
32. "Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
33. Aldosterone escape during ACE inhibitor therapy in chronic heart failure
34. Why does spironolactone improve mortality over and above and ACE inhibitor in chronic heart failure?
35. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces the early morning rise in heart rate failure patients
36. Chronic administration of aldosterone depresses baroreceptor reflex function in the dog
37. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients
38. Collagen in the hypertrophied pressure-overloaded myocardium
39. Aldosterone and heart failure
40. Aldosterone and artery compliance in heart failure
41. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure
42. Mineralocorticoid antagonism reduces Ang II-induced renal injury in stroke-prone hypertensive rats
43. Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation
44. Effects of the selective mineralocorticoid receptor antagonist, eplerenone, in a model of aldosterone-induced hypertension and cardiac fibrosis
45. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression
46. Captopril in heart failure: A double blind controlled trial
47. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
48. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study
49. Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors
50. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure: A report from the AIRE Study Investigators
51. A double-blind randomized placebo controlled study of ramipril vs. spironolactone on left ventricular remodeling after acute myocardial infarction
52. Eplerenone, a novel and selective aldosterone receptor antagonist: Efficacy in patients with mild to moderate hypertension
53. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
54. Randomized placebo-controlled and balloon-angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade
55. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the randomized aldactone evaluation study [RALES])
56. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
57. A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results
58. Randomized trial of intravenous atenolol among 16,027 cases of suspected myocardial infarction: ISIS-1
59. Reducing the risk of coronary events: Evidence from the Scandinavian Simvastatin Survival Study (4S)
60. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels